Table of contents
Volume 94, Issue 2
Published online 24 January 2006 (179-340)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Book Review
Minireviews
Epigenetics provides a new generation of oncogenes and tumour-suppressor genes FREE
M Esteller
Br J Cancer 94: 179-183; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602918
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival FREE
H-W Lo and M-C Hung
Br J Cancer 94: 184-188; doi:10.1038/sj.bjc.6602941
Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence FREE
M S Cunningham, B White, D Hollywood and J O'Donnell
Br J Cancer 94: 189-194; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602917
mTOR signaling: implications for cancer and anticancer therapy FREE
E Petroulakis, Y Mamane, O Le Bacquer, D Shahbazian and N Sonenberg
Br J Cancer 94: 195-199; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602902
Clinical Studies
Increased risk of venous thromboembolism in patients with acute leukaemia FREE
M Mohren, I Markmann, K Jentsch-Ullrich, M Koenigsmann, G Lutze and A Franke
Br J Cancer 94: 200-202; advance online publication, January 17, 2006; doi:10.1038/sj.bjc.6602945
The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma FREE
M Sarbia, M Stahl, C von Weyhern, G Weirich and F Pühringer-Oppermann
Br J Cancer 94: 203-207; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602900
Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer FREE
M R Stockler, M H N Tattersall, M J Boyer, S J Clarke, P J Beale and R J Simes
Br J Cancer 94: 208-212; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602908
Refining the role of laparoscopy and laparoscopic ultrasound in the staging of presumed pancreatic head and ampullary tumours FREE
B N J Thomson, R W Parks, D N Redhead, F K S Welsh, K K Madhavan, S J Wigmore and O J Garden
Br J Cancer 94: 213-217; doi:10.1038/sj.bjc.6602919
Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial FREE
F Donskov, M Hokland, N Marcussen, H H Torp Madsen and H von der Maase
Br J Cancer 94: 218-226; doi:10.1038/sj.bjc.6602937
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer FREE
A M Al Murri, J M S Bartlett, P A Canney, J C Doughty, C Wilson and D C McMillan
Br J Cancer 94: 227-230; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602922
Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study FREE
H M Verkooijen, P O Chappuis, E Rapiti, G Vlastos, G Fioretta, S Sarp, A P Sappino, H Schubert and C Bouchardy
Br J Cancer 94: 231-238; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602914
Determination of TGF
1 protein level in human primary breast cancers and its relationship with survival FREE
S Desruisseau, J Palmari, C Giusti, S Romain, P-M Martin and Y Berthois
Br J Cancer 94: 239-246; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602920
Translational Therapeutics
PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer FREE
T Fujita, H Doihara, K Kawasaki, D Takabatake, H Takahashi, K Washio, K Tsukuda, Y Ogasawara and N Shimizu
Br J Cancer 94: 247-252; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602926
Molecular Diagnostics
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence FREE
N Barnes, P Haywood, P Flint, W F Knox and N J Bundred
Br J Cancer 94: 253-258; advance online publication, January 17, 2006; doi:10.1038/sj.bjc.6602932
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? FREE
L Arnould, M Gelly, F Penault-Llorca, L Benoit, F Bonnetain, C Migeon, V Cabaret, V Fermeaux, P Bertheau, J Garnier, J-F Jeannin and B Coudert
Br J Cancer 94: 259-267; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602930
Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism FREE
D Meierhofer, J A Mayr, K Fink, N Schmeller, B Kofler and W Sperl
Br J Cancer 94: 268-274; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602929
Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma FREE
K Hiraoka, M Miyamoto, Y Cho, M Suzuoki, T Oshikiri, Y Nakakubo, T Itoh, T Ohbuchi, S Kondo and H Katoh
Br J Cancer 94: 275-280; advance online publication, January 17, 2006; doi:10.1038/sj.bjc.6602934
Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients FREE
E Goekkurt, S Hoehn, C Wolschke, C Wittmer, C Stueber, D K Hossfeld and J Stoehlmacher
Br J Cancer 94: 281-286; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602891
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis FREE
D G Ward, Y Cheng, G N'kontchou, T T Thar, N Barget, W Wei, L J Billingham, A Martin, M Beaugrand and P J Johnson
Br J Cancer 94: 287-292; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602923
Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2 FREE
S Kazama, T Watanabe, Y Ajioka, T Kanazawa and H Nagawa
Br J Cancer 94: 293-298; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602927
Genetics and Genomics
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study FREE
F Canzian, J D McKay, R J Cleveland, L Dossus, C Biessy, S Rinaldi, S Landi, C Boillot, S Monnier, V Chajès, F Clavel-Chapelon, B Téhard, J Chang-Claude, J Linseisen, P H Lahmann, T Pischon, D Trichopoulos, A Trichopoulou, D Zilis, D Palli, R Tumino, P Vineis, F Berrino, H B Bueno-de-Mesquita, C H van Gils, P H M Peeters, G Pera, E Ardanaz, M-D Chirlaque, J R Quirós, N Larrañaga, C Martínez-García, N E Allen, T J Key, S A Bingham, K-T Khaw, N Slimani, T Norat, E Riboli and R Kaaks
Br J Cancer 94: 299-307; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602936
Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers FREE
Z Kote-Jarai, A Salmon, T Mengitsu, M Copeland, A Ardern-Jones, I Locke, S Shanley, B Summersgill, Y-J Lu, J Shipley and R Eeles
Br J Cancer 94: 308-310; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602912
BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias FREE
K Konishi, M Takimoto, K Kaneko, R Makino, Y Hirayama, H Nozawa, T Kurahashi, Y Kumekawa, T Yamamoto, H Ito, N Yoshikawa, M Kusano, K Nakayama, B J Rembacken, H Ota and M Imawari
Br J Cancer 94: 311-317; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602911
COSMIC 2005 FREE
S Forbes, J Clements, E Dawson, S Bamford, T Webb, A Dogan, A Flanagan, J Teague, R Wooster, P A Futreal and M R Stratton
Br J Cancer 94: 318-322; advance online publication, January 17, 2006; doi:10.1038/sj.bjc.6602928
Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome FREE
S E Bojesen, O Ammerpohl, A Weinhäusl, O A Haas, H Mettal, R M Bohle, A Borkhardt and U Fuchs
Br J Cancer 94: 323-332; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602939
A multiplex PCR predictor for aCGH success of FFPE samples FREE
E H van Beers, S A Joosse, M J Ligtenberg, R Fles, F B L Hogervorst, S Verhoef and P M Nederlof
Br J Cancer 94: 333-337; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602889
Letters to the Editor
Human papilloma virus and breast cancer FREE
K Altundag and M Z Baptista
Br J Cancer 94: 338; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602944
Reply: Human papilloma virus and breast cancer FREE
C-Y Kan, B J Iacopetta, J S Lawson and N J Whitaker
Br J Cancer 94: 339; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602943
Book Review
Genetic Predisposition to Cancer FREE
F Eisinger
Br J Cancer 94: 340; doi:10.1038/sj.bjc.6602883
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
